sur AMOEBA (EPA:ALMIB)
Amoéba Expands Production to Support AXPERA's Market Launch
Amoéba, a French industrial greentech firm, is extending production capacity at its Chassieu site. This move supports the commercial deployment of their "AXPERA" biocontrol products. The decision follows a memorandum signed with Koppert in 2024, aimed at securing a global contract by May 2025. Recent positive conclusions from the European Food Safety Authority (EFSA) have also paved the way for marketing authorizations expected this year.
The extension involves a €1.1 million investment to increase production and reduce costs through technical improvements. Additionally, Amoéba is exploring further capacity expansions, including partnerships with CDMOs and Koppert. These strategies aim to optimize production for AXPERA's commercial launch, aligning with expected volume increases and cost efficiencies.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de AMOEBA